Vera Petrova
Mannheim, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Immunosuppressive capacity of circulating MDSC predicts response to immune checkpoint inhibitors in melanoma patients.
Journal: Frontiers in immunology
Published: October 10, 2022
HSP90α induces immunosuppressive myeloid cells in melanoma via TLR4 signaling.
Journal: Journal for immunotherapy of cancer
Published: September 01, 2022
Tumor promoting capacity of polymorphonuclear myeloid-derived suppressor cells and their neutralization.
Journal: International journal of cancer
Published: March 31, 2021
IL-6 as a major regulator of MDSC activity and possible target for cancer immunotherapy.
Journal: Cellular immunology
Published: October 23, 2020
Myeloid Cell Modulation by Tumor-Derived Extracellular Vesicles.
Journal: International journal of molecular sciences
Published: July 29, 2020
Modern Aspects of Immunotherapy with Checkpoint Inhibitors in Melanoma.
Journal: International journal of molecular sciences
Published: March 10, 2020
Intraoperative radiotherapy with low energy x-rays for primary and recurrent soft-tissue sarcomas.
Journal: Radiation oncology (London, England)
Published: January 21, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026